Understanding Your Child's Diagnosis: RORC Deficiency and MSMD
At a Glance
Complete RORC deficiency is an inherited immune condition—not something a parent caused—that can make children vulnerable to mycobacterial infections, including BCG, and recurring Candida infections. Diagnosis helps specialists tailor monitoring and treatment.
Receiving a diagnosis of Mendelian Susceptibility to Mycobacterial Disease (MSMD) due to complete RORC deficiency can feel overwhelming, especially if it follows a frightening reaction to a routine vaccine or a long struggle with persistent infections. It is important to know from the start: nothing you did caused this. This is an ultra-rare, inherited condition that affects how a child’s immune system recognizes and fights specific types of germs [1][2].
Understanding MSMD and RORC Deficiency
MSMD is not a single disease but a group of rare genetic conditions that make children uniquely vulnerable to mycobacteria [3]. These include the bacteria that cause tuberculosis, but also “weak” or environmental mycobacteria that typically do not make healthy people sick—including the BCG vaccine (Bacillus Calmette-Guérin), which contains a weakened live bacterium [4][5].
Complete RORC deficiency is a specific, “biallelic” (inherited from both parents) form of MSMD [2]. The RORC gene provides instructions for making proteins (ROR
- Vulnerability to Mycobacteria: The body’s immune cells have an impaired ability to produce interferon-gamma (IFN-
), a vital signaling protein that tells other immune cells to kill mycobacteria [2]. This is why the BCG vaccine, which is safe for most children, can cause a serious or widespread infection in a child with this deficiency [4]. - Vulnerability to Candida: The immune system also has a defect in producing IL-17, a protein needed to protect the skin and mouth from Candida (yeast) [1]. This often results in chronic mucocutaneous candidiasis (CMC), which looks like persistent or recurring oral thrush, severe diaper rash, or nail infections [2].
Note: While Candida and mycobacteria are the primary vulnerabilities, complete RORC deficiency has a variable presentation. Your child may still get common childhood infections, and their severity will depend on your child’s age, overall clinical status, and current treatments.
Validation of the Parental Journey
For many parents, the path to this diagnosis is marked by a “diagnostic odyssey”—a long period of uncertainty, multiple doctor visits, and sometimes the trauma of seeing a child become severely ill after what should have been a standard vaccination [7].
- It was not your fault: Because the BCG vaccine is live, a child with RORC deficiency will react to it because of their underlying genetics, not because of how the vaccine was given or how the child was cared for [1].
- The “Invisible” Defect: Standard immune tests often come back normal in these children [3]. This can lead to delays in diagnosis and may leave parents feeling unheard or questioning their own observations until specialized genetic testing provides the answer [8].
- Genetic Context: This condition is autosomal recessive, meaning both parents must carry a copy of the affected gene for a child to have the condition [2]. Finding this out can bring up complex emotions, but it also provides a clear “map” for doctors to protect future siblings by screening them early with rapid targeted testing or avoiding live vaccines until their status is known [9].
What This Means for Your Child
While the diagnosis is serious, identifying the specific genetic cause is a critical turning point. It allows your medical team to move away from “guessing” and toward a targeted plan.
- Specialized Care: Your child will likely need a multidisciplinary team, including immunologists and infectious disease specialists, to manage infections with specific antimycobacterial and antifungal medications [10][11].
- Targeted Monitoring: Because the immune defect is specific, doctors can focus on monitoring for the types of infections your child is actually particularly susceptible to, rather than worrying about every common cold [12].
- Future Options: Depending on how your child’s immune system functions, some specialists may discuss advanced options like recombinant interferon-gamma or, in some cases, hematopoietic stem cell transplantation (HSCT) to “reset” the immune system [13][14].
This diagnosis is the first step in building a protective shield around your child. By knowing exactly where the gaps in their immune system are, you and your doctors can work together to fill them [15].
Common questions in this guide
What does a complete RORC deficiency diagnosis mean for my child?
Why can the BCG vaccine cause an infection in a child with RORC deficiency?
What infections are children with complete RORC deficiency most at risk for?
How is complete RORC deficiency confirmed?
What treatment might my child need for RORC deficiency?
Should my child's siblings be tested before receiving live vaccines?
Did I cause my child's RORC deficiency or BCG reaction?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Finding the cause
Would specialized genetic testing confirm the cause of my child's condition?
Specialized care
What kinds of specialists would be part of my child's care?
Future treatment options
Could my child's care team discuss advanced options like stem cell transplantation?
Get notified when new evidence is published on Mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations.
Okada S, Markle JG, Deenick EK, et al.
Science (New York, N.Y.) 2015; (349(6248)):606-613 doi:10.1126/science.aaa4282.
PMID: 26160376 - 2
Human inherited RORγT deficiency encompasses genetic heterogeneity, T cell deficiency, and clinical homogeneity.
Fagniez I, Tsumura M, Guerin A, et al.
medRxiv : the preprint server for health sciences 2026; doi:10.64898/2026.07.18.26358075.
PMID: 42539146 - 3
Clinical recommendations for diagnosis and management of Mendelian susceptibility to mycobacterial disease in resource-limited settings.
Cornelissen H, Glanzmann B, van Coller A, et al.
The journal of allergy and clinical immunology. Global 2025; (4(4)):100540 doi:10.1016/j.jacig.2025.100540.
PMID: 41048447 - 4
Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds.
Errami A, Baghdadi JE, Ailal F, et al.
Journal of clinical immunology 2023; (43(4)):728-740 doi:10.1007/s10875-022-01419-x.
PMID: 36630059 - 5
Evaluation of interleukin-12 receptor β1 and interferon gamma receptor 1 deficiency in patients with disseminated BCG infection.
Pourakbari B, Hosseinpour Sadeghi R, Mahmoudi S, et al.
Allergologia et immunopathologia 2019; (47(1)):38-42 doi:10.1016/j.aller.2018.06.005.
PMID: 30268380 - 6
RORγt and RORα signature genes in human Th17 cells.
Castro G, Liu X, Ngo K, et al.
PloS one 2017; (12(8)):e0181868 doi:10.1371/journal.pone.0181868.
PMID: 28763457 - 7
Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD): a case series.
Mahdaviani SA, Fallahi M, Jamee M, et al.
Annals of clinical microbiology and antimicrobials 2022; (21(1)):8 doi:10.1186/s12941-022-00500-y.
PMID: 35232430 - 8
Phenotypic and immune functional profiling of patients with suspected Mendelian Susceptibility to Mycobacterial Disease in South Africa.
van Coller A, Glanzmann B, Cornelissen H, et al.
BMC immunology 2021; (22(1)):62 doi:10.1186/s12865-021-00452-6.
PMID: 34517836 - 9
Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): A systematic review.
Khavandegar A, Mahdaviani SA, Zaki-Dizaji M, et al.
The Journal of allergy and clinical immunology 2024; (153(5)):1432-1444 doi:10.1016/j.jaci.2024.01.021.
PMID: 38341181 - 10
Mendelian susceptibility to mycobacterial disease in tuberculosis-hyperendemic South Africa.
Cornelissen HM, Glanzmann B, Van Coller A, et al.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2021; (111(10)):998-1005 doi:10.7196/SAMJ.2021.v111i10.15341.
PMID: 34949297 - 11
Mendelian susceptibility to mycobacterial disease: IFN-γ-driven immunity collapse underlies heterogeneous infections.
Qian M, Zhou J, Zhou Q, et al.
Frontiers in immunology 2026; (17()):1781297 doi:10.3389/fimmu.2026.1781297.
PMID: 42183200 - 12
Persistent Ascites Revealing Mendelian Susceptibility to Mycobacterial Disease Due to IL-12Rβ1 Deficiency: A Case Report and Review of the Literature.
Dolikhani M, Shakibamaram G, Rashtian P, et al.
Case reports in immunology 2026; (2026()):3587297 doi:10.1155/crii/3587297.
PMID: 42643649 - 13
Mendelian susceptibility to mycobacterial diseases: State of the puzzle.
Errami A, Bousfiha AA
Qatar medical journal 2023; (2023(2)):25 doi:10.5339/qmj.2023.sqac.25.
PMID: 38025345 - 14
Tailored conditioning for hematopoietic stem cell transplantation in children with Mendelian susceptibility to mycobacterial disease: A tale of two pathways for IFN-γ and IL-12 defects.
Ganesan K, Balwani M, Seshadri N, et al.
Journal of human immunity 2026; (2(5)):e20250264 doi:10.70962/jhi.20250264.
PMID: 42516312 - 15
What We Have Here Is a Failure to Communicate: Interleukin-12 / Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial Disease.
Johnston AΜ, Rider NL, Freeman AF, et al.
The journal of allergy and clinical immunology. In practice 2026; (14(7)):1529-1539 doi:10.1016/j.jaip.2026.02.026.
PMID: 41786143
This page is for informational purposes only and does not constitute medical advice. Your child's immunology and infectious disease team should interpret test results and guide vaccine and treatment decisions.